The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction

Author:

Carey Matthew R.1ORCID,Ladanyi Annamaria1,Mehlman Yonatan1,Molinsky Rebecca L.2ORCID,Eisenberger Andrew3,Clerkin Kevin J.1ORCID,Aaron Justin G.4,Takeda Koji5,Sayer Gabriel T.1,Uriel Nir1,Demmer Ryan T.2,Colombo Paolo C.1,Yuzefpolskaya Melana1

Affiliation:

1. Division of Cardiology Department of Medicine NewYork‐Presbyterian Columbia University Irving Medical Center New York New York USA

2. Division of Epidemiology and Community Health School of Public Health University of Minnesota Minneapolis Minnesota USA

3. Division of Hematology/Oncology Department of Medicine NewYork‐Presbyterian/Columbia University Irving Medical Center New York New York USA

4. Division of Infectious Diseases Department of Medicine NewYork‐Presbyterian/Columbia University Irving Medical Center New York New York USA

5. Division of Cardiac Thoracic & Vascular Surgery Department of Surgery NewYork‐Presbyterian Columbia University Irving Medical Center New York New York USA

Abstract

AbstractBackgroundHeart transplantation (HT) is the gold standard therapy for advanced heart failure, providing excellent long‐term outcomes. However, postoperative outcomes are limited by bleeding, infections, and primary graft dysfunction (PGD) that contribute to early mortality after HT. HT candidates with pre‐existing hematologic disorders, bleeding, and clotting, may represent a higher risk population. We assessed the short‐ and long‐term outcomes of patients with pre‐existing hematologic disorders undergoing HT.Methods and resultsMedical records of all adult patients who received HT from January 2010 to December 2019 at our institution were retrospectively reviewed. Hematologic disorders were identified via chart review and adjudicated by a board‐certified hematologist. Inverse probability weighting and multivariable models were used to adjust for potential pretransplant confounders. Four hundred and ninety HT recipients were included, of whom 29 (5.9%) had a hematologic disorder. Hematologic disorders were associated with severe PGD requiring mechanical circulatory support (aOR 3.15 [1.01–9.86]; p = .049), postoperative infections (aOR 2.93 [1.38–6.23]; p = .01), and 3‐year acute cellular rejection (ACR) (≥1R/1B) (aSHR 2.06 [1.09–3.87]; p = .03). There was no difference in in‐hospital mortality (aOR 1.23 [.20–7.58], p = .82) or 3‐year mortality (aHR 1.58 [.49–5.12], p = .44).ConclusionsPatients with hematologic disorders undergoing HT are at increased risk of severe PGD, postoperative infections, and ACR, while in‐hospital and 3‐year mortality remain unaffected.

Publisher

Wiley

Subject

Transplantation

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Acute complication posttransplant: primary allograft dysfunction;Current Opinion in Organ Transplantation;2023-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3